CompletedNCT00249574
Buprenorphine support before hepatitis C treatment for people using heroin
About this title
Read the official source — NCT00249574Medication studyAges 18–80United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 80 years.
- Listed locations
- OaklandSee all locations and recruitment
Study information
Study start dateJune 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT00249574
- Official title
Show the full official title
HCV Treatment of IDUs After Buprenorphine Stabilization
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Oakland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine/naloxone and pegInterferon.
Who was this study for?
Listed age limits: 18 years to 80 years.
